COPENHAGEN, Denmark, November 26, 2025 – Bavarian Nordic A/S invites its shareholders for a meeting and dialogue with the company’s board and management, who will provide the state of business…
Piramal Pharma Solutions implemented a robust action plan to address evolving regulatory requirements pertaining to nitrosamine impurities. Through comprehensive risk assessments, confirmatory testing, and control strategies, the Company is ensuring…
Piramal Pharma Solutions implemented a robust action plan to address evolving regulatory requirements pertaining to nitrosamine impurities. Through comprehensive risk assessments, confirmatory testing, and control strategies, the Company is ensuring…
, /PRNewswire/ — mAIbe et LenioBio ont le plaisir d’annoncer une nouvelle collaboration stratégique visant à accélérer la découverte et la validation expérimentale d’anticorps monoclonaux de nouvelle génération. En combinant…
, /PRNewswire/ — CaliberMRI, an industry leader in standardizing Magnetic Resonance Imaging (MRI), announced the release of a new quantitative MRI phantom compatible with the Medium ACR phantom. CaliberMRI’s qDisc…
, /PRNewswire/ — Cure SMA, the leading nonprofit organization dedicated to supporting those impacted by spinal muscular atrophy (SMA), welcomes the FDA approval of Itvisma™ (onasemnogene abeparvovec-brve) by Novartis for…
French operations to be concentrated at its Lyon site Final consolidation of R&D in Vienna Saint-Herblain (France), November 26, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA) today announced a strategic…
, /PRNewswire/ — TCI Biotech (TCI Co., Ltd.), a global CDMO+ specializing in functional foods, nutraceuticals, and beauty supplementation, today announced the launch of the TCI Advanced Performance Nutrition Research…
NEW YORK, Nov. 26, 2025 (GLOBE NEWSWIRE) — IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulatory, off-the-shelf therapeutic cancer vaccines, today announced the Company’s participation in the…
JOTO PR Disruptors™ has signed First Ascent Biomedical to amplify its AI-driven precision medicine technology transforming cancer treatment. , /PRNewswire/ — In the race against cancer, where every day counts,…